Breckenridge Pharmaceutical, Inc. is recalling various lots of Alprazolam (alprazolam) and Clobazam (clobazam) tablets due to potential cross-contamination issues during the manufacturing process in India. No illnesses or injuries have been reported to date regarding this recall. These prescription medications were distributed nationwide to pharmacies and are being recalled as a precautionary measure to ensure patient safety.
Deviations in manufacturing standards may have caused these medications to be contaminated with other substances. This poses a potential health risk as contamination could lead to unexpected side effects or impact how well the medication works for the patient.
You have 2 options:
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.